Preclinical Development Planning for Emerging Pharma and Biotech Firms
D5LR VS PLR
Peclinical development2003
1 Design of Dose Response Clinical Trials Boston Chapter of ASA April 10, 2006 Naitee Ting, Pfizer Global R&D.
Confidentiality and trial integrity issues for monitoring adaptive design trials Paul Gallo FDA-Industry Workshop September 28, 2006.
Effectiveness Evaluation for Production Drugs Crystal Groesbeck, Ph.D Division of Production Drugs.
Ich guidelines
11 the added value of cellular analysis in early clinical trials roger greathead - pra international
Adaptive Clinical Trials: Role of Modelling and Simulation
E00 program-level modeling and simulation experiences
International Guidelines and Regulatory Agencies for Toxicity Studies
(NEW) ICH Guidelines Revised 2006
